These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 38599340

  • 1. Circulating plasma cells as a predictive biomarker in Multiple myeloma: an updated systematic review and meta-analysis.
    Li Q, Ai L, Zuo L, Li J, Zhao F, Xu A, Zhang B, Cai L, Hu Y, Sun C.
    Ann Med; 2024 Dec; 56(1):2338604. PubMed ID: 38599340
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of circulating plasma cells in patients with multiple myeloma: A meta-analysis.
    Li J, Wang N, Tesfaluul N, Gao X, Liu S, Yue B.
    PLoS One; 2017 Dec; 12(7):e0181447. PubMed ID: 28704521
    [Abstract] [Full Text] [Related]

  • 3. The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma.
    Galieni P, Travaglini F, Vagnoni D, Ruggieri M, Caraffa P, Bigazzi C, Falcioni S, Picardi P, Mazzotta S, Troiani E, Dalsass A, Mestichelli F, Angelini M, Camaioni E, Maravalle D, Angelini S, Pezzoni V.
    Br J Haematol; 2021 May; 193(3):542-550. PubMed ID: 33792026
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of circulating plasma cells detected by flow cytometry in newly diagnosed multiple myeloma patients: a systematic review and meta-analysis.
    Liu X, Wu F, Ye W, Deng J, Zhang M, Zhang C, Yu Q, Cao L, Gan S, Ma J.
    BMJ Open; 2024 Jan 12; 14(1):e071548. PubMed ID: 38216195
    [Abstract] [Full Text] [Related]

  • 5. Circulating Plasma Cells at the Time of Collection of Autologous PBSC for Transplant in Multiple Myeloma Patients is a Negative Prognostic Factor Even in the Age of Post-Transplant Maintenance Therapy.
    Cowan AJ, Stevenson PA, Libby EN, Becker PS, Coffey DG, Green DJ, Hyun TS, Fromm JR, Gopal AK, Holmberg LA.
    Biol Blood Marrow Transplant; 2018 Jul 12; 24(7):1386-1391. PubMed ID: 29481870
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of circulating clonal plasma cells in newly diagnosed multiple myeloma.
    Han W, Jin Y, Xu M, Zhao SS, Shi Q, Qu X, Zhang R, Li J, Wu Y, Chen L.
    Hematology; 2021 Dec 12; 26(1):510-517. PubMed ID: 34314294
    [Abstract] [Full Text] [Related]

  • 7. Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells.
    Gonsalves WI, Jevremovic D, Nandakumar B, Dispenzieri A, Buadi FK, Dingli D, Lacy MQ, Hayman SR, Kapoor P, Leung N, Fonder A, Hobbs M, Hwa YL, Muchtar E, Warsame R, Kourelis TV, Russell S, Lust JA, Lin Y, Go RS, Siddiqui MA, Kyle RA, Gertz MA, Rajkumar SV, Kumar SK.
    Am J Hematol; 2020 Mar 12; 95(3):310-315. PubMed ID: 31867775
    [Abstract] [Full Text] [Related]

  • 8. The prognostic significance of circulating plasma cells in newly diagnosed multiple myeloma patients.
    Yao W, Yang H, You H, Shang J, Zhai Y, Yan Z, Yan S, Shi X, Yao Y, Wang J, Wang P, Xu Y, Jin S, Yan L, Wu D, Fu C.
    Front Oncol; 2023 Mar 12; 13():1266868. PubMed ID: 37799469
    [Abstract] [Full Text] [Related]

  • 9. Circulating plasma cells in newly diagnosed symptomatic multiple myeloma as a possible prognostic marker for patients with standard-risk cytogenetics.
    Vagnoni D, Travaglini F, Pezzoni V, Ruggieri M, Bigazzi C, Dalsass A, Mestichelli F, Troiani E, Falcioni S, Mazzotta S, Natale A, Angelini M, Ferretti S, Angelini S, Galieni P.
    Br J Haematol; 2015 Aug 12; 170(4):523-31. PubMed ID: 26010293
    [Abstract] [Full Text] [Related]

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 11. Detection of circulating plasma cells in peripheral blood using deep learning-based morphological analysis.
    Chen P, Zhang L, Cao X, Jin X, Chen N, Zhang L, Zhu J, Pan B, Wang B, Guo W.
    Cancer; 2024 May 15; 130(10):1884-1893. PubMed ID: 38236717
    [Abstract] [Full Text] [Related]

  • 12. R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study.
    Chu B, Wang YT, Gao S, Shi L, Lu MQ, Fang LJ, Xiang QQ, Chen Y, Wang MZ, Wang LF, Sun K, Yang J, Duan F, Bao L.
    Ann Hematol; 2024 Sep 15; 103(9):3677-3690. PubMed ID: 38955826
    [Abstract] [Full Text] [Related]

  • 13. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G, Qin X, Acharya C, Xu Y, Deng S, Shi L, Zang M, Sui W, Yi S, Li Z, Hao M, Feng X, Jin F, Zou D, Qi J, Zhao Y, Tai YT, Wang J, Qiu L.
    Ann Hematol; 2015 Feb 15; 94(2):257-64. PubMed ID: 25231928
    [Abstract] [Full Text] [Related]

  • 14. Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
    Bae MH, Park CJ, Kim BH, Cho YU, Jang S, Lee DH, Seo EJ, Yoon DH, Lee JH, Suh C.
    Cytometry B Clin Cytom; 2018 May 15; 94(3):493-499. PubMed ID: 29220877
    [Abstract] [Full Text] [Related]

  • 15. Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era.
    Chakraborty R, Muchtar E, Kumar SK, Jevremovic D, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA.
    Blood Cancer J; 2016 Dec 16; 6(12):e512. PubMed ID: 27983726
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
    Han L, Chen W, Zhao Q.
    Tumour Biol; 2014 Mar 16; 35(3):2473-80. PubMed ID: 24218336
    [Abstract] [Full Text] [Related]

  • 17. The detection of circulating tumor cells indicates poor therapeutic efficacy and prognosis in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
    Wang S, Liu X, Lv H, Yu J, Li H.
    J Evid Based Med; 2024 Jun 16; 17(2):329-340. PubMed ID: 38600712
    [Abstract] [Full Text] [Related]

  • 18. The Prognostic Role of Cyclin D1 in Multiple Myeloma: A Systematic Review and Meta-Analysis.
    Jiang Y, Zhang C, Lu L, Wang X, Liu H, Jiang Y, Hong L, Chen Y, Huang H, Guo D.
    Technol Cancer Res Treat; 2022 Jun 16; 21():15330338211065252. PubMed ID: 35098809
    [Abstract] [Full Text] [Related]

  • 19. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
    Qin J, Ke B, Liu T, Kong C, Li A, Fu H, Jin C.
    Cancer Med; 2023 Feb 16; 12(3):2199-2218. PubMed ID: 36057947
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
    García de Veas Silva JL, Bermudo Guitarte C, Menéndez Valladares P, Rojas Noboa JC, Kestler K, Duro Millán R.
    PLoS One; 2016 Feb 16; 11(11):e0166841. PubMed ID: 27893836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.